PAREXEL Launches Perceptive® Cloud for the Life Sciences Industry
BOSTON, December 12, 2017-PAREXEL International Corporation, a leading global biopharmaceutical services organization, today introduced the Perceptive® Cloud to the life sciences industry, as part of the organization’s recent alliance with Microsoft Corp.
Perceptive Cloud elevates PAREXEL Informatics solutions into an enhanced cloud infrastructure built on Microsoft Azure, combining PAREXEL’s extensive industry expertise and innovative technology solutions with the power of Microsoft’s intelligent cloud services and investment in global compliance certifications and enterprise-grade security. The first group of integrated cloud services will include LIQUENT InSight® Regulatory Information Management (RIM), Study Start-Up, DataLabs® Electronic Data Capture (EDC), Managed Access Programs, and IMPACT ® Clinical Trial Management (CTMS).
“In drug development today, the time to treatment continues to grow longer. This is due, in large part, to the use of conventional, disparate systems that simply digitize manual processes,” said Paul Bidez, Vice President of Regulatory and Clinical Solutions for PAREXEL. “Perceptive Cloud represents an opportunity to automate and streamline workflows and provide greater access to high quality data, simplifying the drug development journey with the objective of ultimately bringing new therapies to patients sooner.”
Perceptive Cloud is designed to respond to the need within healthcare to deliver cost-effective innovation while trusting that sensitive information will stay secure across global environments. Introducing Perceptive Cloud represents the first milestone of the enterprise alliance between PAREXEL and Microsoft aimed at leveraging the cloud to optimize performance and jointly innovate to offer new clinical development solutions and more site- and patient-centric technologies.
“Most life sciences solutions to date have been developed with the end result in mind, not the user experience, creating bottlenecks and inefficiencies across the drug development chain,” said Paul Slater, Worldwide Industry Strategist, Pharmaceuticals, Microsoft Health. “Both Microsoft and PAREXEL are committed to developing technologies that better engage patients, sites and sponsors to optimize clinical and operational effectiveness and digitally transform health. The Perceptive Cloud is only the first step in this effort.”
PAREXEL Informatics delivers innovative technology solutions to help optimize patient engagement, clinical and regulatory processes, and provides analytics and visualization for PAREXEL’s Connected Journey™ of data-driven services. PAREXEL’s Connected Journey of technology, processes, and expertise supports clinical development and commercialization, with solutions to provide data-driven insights that enable our clients to make critical decisions more quickly. For more information on Perceptive Cloud, visit www.PAREXEL.com/Perceptive-Cloud.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology, and medical device industries. Committed to providing solutions intended to expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the integrated clinical development and regulatory information management process. Headquartered near Boston, Massachusetts, PAREXEL has approximately 18,900 employees with offices in 85 locations in 52 countries around the world. For more information about PAREXEL International visit www.PAREXEL.com.
PAREXEL and PAREXEL Informatics are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates. All other trademarks are the property of their respective owners.
# # #
PAREXEL Contacts:
Media:
Wendy Ryan
Tel.: +1 781-434-5104
Email: Wendy.Ryan@PAREXEL.com
Dana Robie
Tel.: +1 781-434-4772
Email: Dana.Robie@PAREXEL.com
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
